Scarlettie Books

Scott Rocklage of 5AM Ventures Does an Interview with Ideamensch

Dr. Scott Rocklage was asked of a trend that he finds very interesting and exciting right now. He responded by saying he he thinks the ability to now target specific types of mutations or genotypes to help treat cancer is an incredible development in oncology. Dr. Rocklage says that these development have already helped save lives and extend the lifespan of many others suffering from cancer. Dr. Scott Rocklage expects many more developments in this field and he finds it very exciting.

Another question posed to Scott Rocklage of 5AM Ventures was if he was to start his business over again, would would he do differently the next time around. Dr. Rocklage’s answer was that he would concentrate much more on the people at his company. People are what make the company grow and prosper and building a good team should not be underestimated in any business says Rocklage.

Next, Ideamensch asked what is one thing that that Scott Rocklage does constantly in business that he suggests other people try out themselves. Scott Rocklage says that one of the best thing any entrepreneur can do is take measured risk taking. He went on to say that you have the best grip on your own future when you have your own business and not when you work for a Fortune 500 company. Taking measured risks and having your own business will let you try new opportunities and have the greatest control of your own life summarizes Scott Rocklage. That is a very empowering thing to have and learn more about Scott.

Scott Rocklage was asked about a strategy that has helped him to expand his business and how it has done so. The strategy that has helped Scott Rocklage expand his firm’s business is a simple one. He says that simply staying true to what his firm knows how to do best and not moving too far away from the company’s strength has been a proven successful strategy for him. Keeping this in mind is especially important when things get tough says Rocklage. During tough times, it is tempting to move away from what your specialize and to try a new trend instead. This could backfire tremendously though and Scott avoids putting himself in such a situation and his Linkedin.

More visit:

Why Clay Siegall is transforming the art of cancer treatment

Cancer has been attributed to causing many deaths across the world. This is because it is categorized as one of the chronic diseases that is very expensive to cure. As a result, many organizations have been founded to try and find the cure to the disease that has been contributed to many deaths globally. Many people have also taken key interest in specializing and studying cancer cases in a bid to combat the disease. Clay Siegall is the co-founder and president of the Seattle Genetics which is a center for scientific research and drug development. The center also takes keen interest in helping patients understand the type of diseases affecting them and how to manage or treat it. As such, Clay Siegall vast knowledge in the field of scientific research has brought a lot of change regarding the development of advance drugs to cure chronic diseases like cancer. He has spearheaded the development of antibody-drug conjugates that have been using used in over 60 countries across the world. These are drugs that have helped mitigate and treat many cases of cancer.

According to, Clay Siegall received a lot of recognition when the then Vice President of the united states of America JoeBiden visited Seattle Genetics. As a result, many media houses have focused on the company and Clay Siegall in particular. He also seeks to grow the company into a multinational entity and produced more effective drugs to curb the spread of cancer. Due to its rapid expansion, the company has opened employment opportunities to over 100 employees adding to the existing number of personnel. Clay Siegall responsibility at the company is to make sure the research being done to develop new drugs meets international standards. He is mandated with releasing tested and proven cancer treatment drugs that have also elevated the name of his company. Research is carried out on a daily basis in a bid to keep on with the emerging market trends and technological advancement. His innovative capabilities made him start capital raising activity in order to enable the research center perform to its fullest. As a result he raised over $1.2billion from the public